CM
MIST icon

Caption Management’s Milestone Pharmaceuticals MIST Stock Holding History

Caption Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,378
Closed -$233K – 1548
2022
Q3 		$233K Buy
+25,378
New +$192K ﹤0.01% 1223

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caption Management's MIST Position: Q4 2022 in Review

Caption Management sold out of Milestone Pharmaceuticals (MIST) in Q4 2022, closing a stake of 25,378 shares — an estimated $233K sold.

Caption Management first reported a position in MIST in Q3 2022 and held it in 1 quarter. The position peaked at $233K in Q3 2022. 56 funds tracked by Wall St. Rank hold MIST as of Q4 2022.

  • Caption Management reported no remaining Milestone Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Caption Management sold 25,378 Milestone Pharmaceuticals shares in Q4 2022, an estimated $233K.
  • Caption Management first reported a position in Milestone Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • Caption Management's Milestone Pharmaceuticals position peaked at $233K in Q3 2022.
  • 56 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.